‘Open Innovation’ will bring a new business model for both domestic and multinational pharmaceutical companies
Companies being thirst on new drugs are breaking through the ‘Open Innovation’. The Korean pharmaceutical industry has stepped its first step.
The pharmaceutical industry have taken the meaning of the ’Open Innovation’ not as methods to have new drug development and pipeline securement at once, ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
